Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | HPGD | P15428 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | CCR6 | P51684 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9474105 | 0.93 | TSHR (0.48) | TSHRALDH1A1HPGDLMNAALOX12 | |
| SCHEMBL11327615 | 0.93 | ALDH1A1 (0.62) | TSHRALDH1A1HPGDLMNAALOX12 | |
| SCHEMBL176438 | 0.90 | MEN1 (0.47) | TSHRALDH1A1HPGDLMNAALOX12 | |
| SCHEMBL9978463 | 0.89 | TSHR (0.48) | TSHRALDH1A1HPGDLMNAALOX12 | |
| SCHEMBL8089365 | 0.89 | HPGD (0.62) | TSHRALDH1A1HPGDMAPTOPRM1 | |
| SCHEMBL30578615 | 0.86 | TSHR (0.46) | TSHRALDH1A1HPGDLMNAALOX12 | |
| SCHEMBL176463 | 0.86 | POLB (0.48) | TSHRALDH1A1HPGDLMNAALOX12 | |
| SCHEMBL9474547 | 0.86 | TSHR (0.49) | TSHRALDH1A1HPGDLMNAALOX12 | |
| SCHEMBL11184042 | 0.84 | TSHR (0.53) | TSHRALDH1A1HPGDLMNAALOX12 | |
| SCHEMBL9543520 | 0.82 | TSHR (0.51) | TSHRALDH1A1HPGDLMNAALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119529328-A | Metal-coated organosilicon elastomer microsphere, and preparation method and application thereof | 江苏涌新材料科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-117247678-A | Heat-conducting silicone grease and preparation method thereof | 苏州天脉导热科技股份有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-117164784-A | Modified organosilicon microsphere and preparation method and application thereof | 江苏涌新材料科技有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-116003800-A | Organosilicon-based polycarbonate flame retardant and application thereof | 江苏涌新材料科技有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-113667449-A | Double-sided adhesive tape for low-surface-energy silicon rubber surface and preparation method thereof | 江苏斯迪克新材料科技股份有限公司 | 2021-11-19 | — | — | CN | claimed |
| CN-111117481-B | Addition type organic silicon liquid coating material and preparation method and application thereof | 江苏微上新材料科技有限公司 | 2021-10-22 | — | — | CN | claimed |
| EP-3758706-A2 | WEE1 KINASE INHIBITORS AND METHODS OF TREATING CANCER USING THE SAME | The Regents Of The University Of Colorado (US) | 2021-01-06 | — | — | EP | claimed |
| US-20200405723-A1 | WEE1 KINASE INHIBITORS AND METHODS OF TREATING CANCER USING THE SAME | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2020-12-31 | — | — | US | claimed |
| CN-111171716-A | Epoxy silicone rubber coating material and preparation method and application thereof | 江苏微上新材料科技有限公司 | 2020-05-19 | — | — | CN | claimed |
| CN-111117481-A | Addition type organic silicon liquid coating material and preparation method and application thereof | 江苏微上新材料科技有限公司 | 2020-05-08 | — | — | CN | claimed |
| US-8530550-B2 | Crosslinkable rubber composition | MITSUI CHEMICALS, INC. (JP) | 2013-09-10 | — | — | US | claimed |
| US-6921829-B2 | Method for formulating organic compounds | MERCK PATENT GMBH (DE) | 2005-07-26 | — | — | US | claimed |
| US-20030139630-A1 | Method for formulating organic compounds | MERCK PATENT GMBH (DE) | 2003-07-24 | — | — | US | claimed |
| EP-0720853-B1 | Topical administrable zinc phtalocyanine compositions | NOVARTIS AG (CH) | 2001-07-11 | — | — | EP | claimed |
| US-5723148-A | ZINC PHTHALOCYANINE, MONOALKYL ETHER OF DIETHYLENE GLYCOL | NOVARTIS CORP. (US) | 1998-03-03 | — | — | US | claimed |
| US-5616602-A | SKIN DISORDERS | CIBA-GEIGY CORPORATION (US) | 1997-04-01 | — | — | US | claimed |
| EP-0720853-A1 | Topical administrable zinc phtalocyanine compositions | CIBA-GEIGY AG (CH) | 1996-07-10 | — | — | EP | claimed |
| EP-0633024-A1 | Topically administrable zinc phthalocyanine compositions | CIBA-GEIGY AG (CH) | 1995-01-11 | — | — | EP | claimed |
| US-4540650-A | Photoresists suitable for forming relief structures of highly heat-resistant polymers | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1985-09-10 | — | — | US | claimed |
| US-4438151-A | ADDITION COPOLYMERIZATION ON SURFACE | TEIJIN LIMITED (JP) | 1984-03-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200405723-A1 | WEE1 KINASE INHIBITORS AND METHODS OF TREATING CANCER USING THE SAME | WEE1, WEE2, NME1 | TSHR 3859/4885ALDH1A1 3933/4885HPGD 2372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.